TGM2 activity contributes to the severity of tissue damage in mouse models of amyotrophic lateral sclerosis, Huntington’s disease, multiple sclerosis, and stroke [39–42]. This evidence concerns the gene TGM2 and amyotrophic lateral sclerosis.